← Leaderboards
Yuping Mei
Johns Hopkins University
$1,082,183
Attributed
$1,579,574
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $331.6K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,579,574 · 3
By mechanism
UH3$994,782 · 1
R21$421,042 · 1
R03$163,750 · 1
Top collaborators
- Malcolm V Brock3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Daniel W Chan$17,758,540
- Andrew J Cherlin$17,890,824
- Zhen Zhang$10,302,020
- Maria E. Trent$10,876,537
- Subhra Chakraborty$7,655,819
Others in their field
Other Emerging Leaders on “Survival Rate”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Phd, Stephen Schwartz · Fred Hutchinson Cancer Research Center$21,360,715
- Scarlett Lin-Gomez · University Of California, San Francisco$18,598,737
- Mary Charlton · University Of Iowa$16,748,573
- Lihua Liu · University Of Southern California$16,229,586
- Eric Durbin · University Of Kentucky$13,607,670
Research focus
Survival RateMalignant Neoplasm Of LungDeep SequencingNon-Small-Cell Lung CarcinomaLung NoduleBiologicalTissuesMalignant - DescriptorBenignBiopsyMalignant NeoplasmsSpecimenSensitivity And SpecificityBiological MarkersStructure Of Parenchyma Of LungPlayDiagnosisLaboratoriesProtein FunctionCancer EtiologyHistologicCessation Of LifeIn VitroPlasma
Grant awards (7)
Mechanistic and therapeutic insights into druggable AA-pfeRNA in lung cancer$229,659
R21 · FY2025 · CA · contact PI
Ethnicity-driven pfeRNA in African American health disparities in lung cancer.$191,383
R21 · FY2024 · CA · contact PI
Identify the target proteins of one ADC-specific and two SCC-specific pfeRNAs and investigate the mechanisms underlying the pfeRNA-protein interaction.$81,875
R03 · FY2024 · CA · contact PI
Identify the target proteins of one ADC-specific and two SCC-specific pfeRNAs and investigate the mechanisms underlying the pfeRNA-protein interaction.$81,875
R03 · FY2023 · CA · contact PI
Developing a CLIA compliant LDT for detecting plasma piR-Ls/pfeRNAs to distinguish benign and malignant lung nodules$331,594
UH3 · FY2021 · CA
Developing a CLIA compliant LDT for detecting plasma piR-Ls/pfeRNAs to distinguish benign and malignant lung nodules$331,594
UH3 · FY2020 · CA
Developing a CLIA compliant LDT for detecting plasma piR-Ls/pfeRNAs to distinguish benign and malignant lung nodules$331,594
UH3 · FY2019 · CA